XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus)

XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus) - XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045811

Enrollment

480

Registered

2021-11-15

Start date

2021-11-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis for influenza virus infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Household members who live with an influenza-infected index patient

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Incidence rates of fever and respiratory symptoms (cough or nasal discharge / nasal congestion)	—

Secondary

Measure	Time frame
Rates of influenza virus positive subjects with fever and respiratory symptoms (cough or nasal discharge / nasal congestion)	—

Countries

Japan

Contacts

Public ContactSatoru Takashima

Shionogi & Co., Ltd. Pharmacovigilance Department

satoru.takashima@shionogi.co.jp+81-6-6209-6974

Outcome results